Betaxolol
Back to searchMolecule Structure
Scientific Name
Betaxolol
Description of the Drug
Betaxolol is a cardioselective beta blocking agent commonly used to treat hypertension and elevated intraocular pressure (when administered ophthalmically).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00195
http://www.drugbank.ca/drugs/DB00195
Brand Name(s)
Betoptic, Betoptic susp
Company Owner(s)
Epic Pharma Llc, Apotex Inc, Medimetriks Pharmaceuticals Inc, Sandoz Inc, Acella Pharmaceuticals Llc, Alcon Laboratories Inc, Kvk Tech Inc, Novartis Pharmaceuticals Corp, Sanofi Aventis Us Llc, Akorn Operating Co Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL23530 | |||
PharmGKB | PA448611 | |||
Human Metabolome Database | HMDB0014341 | |||
DrugBank | DB00195 | |||
PubChem: Thomson Pharma | 14776435 | |||
PubChem | 2369 | |||
LINCS | LSM-1255 | |||
Nikkaji | J19.271F | |||
BindingDB | 50405521 | |||
EPA CompTox Dashboard | DTXSID2022674 | |||
DrugCentral | 356 | |||
ChemicalBook | CB1134548 | |||
Guide to Pharmacology | 549 | |||
rxnorm | BETOPTIC S | BETAXOLOL | KERLONE | BETAXOLOL HYDROCHLORIDE |
KEGG Ligand | C06849 | |||
ChEBI | 3082 |